Dr. Rishabh Sachdev, M.D

NPI: 1346650470
Total Payments
$565.69
2023 Payments
$231.80
Companies
9
Transactions
12
Medicare Patients
796
Medicare Billing
$94,080

Payment Breakdown by Category

Food & Beverage$565.69 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $565.69 12 100.0%

Top Paying Companies

Company Total Records Latest Year
Mallinckrodt Hospital Products Inc. $162.95 2 $0 (2023)
Janssen Biotech, Inc. $117.18 1 $0 (2023)
Regeneron Healthcare Solutions, Inc. $81.48 1 $0 (2022)
Boston Scientific Corporation $75.14 1 $0 (2019)
AbbVie Inc. $46.72 2 $0 (2021)
Takeda Pharmaceuticals U.S.A., Inc. $33.62 2 $0 (2021)
PFIZER INC. $17.35 1 $0 (2021)
Gilead Sciences, Inc. $15.89 1 $0 (2021)
Intercept Pharmaceuticals, Inc. $15.36 1 $0 (2020)

Payment History by Year

Year Amount Transactions Top Company
2023 $231.80 2 Janssen Biotech, Inc. ($117.18)
2022 $129.81 2 Regeneron Healthcare Solutions, Inc. ($81.48)
2021 $98.93 5 AbbVie Inc. ($46.72)
2020 $15.36 1 Intercept Pharmaceuticals, Inc. ($15.36)
2019 $89.79 2 Boston Scientific Corporation ($75.14)

All Payment Transactions

12 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
04/26/2023 Janssen Biotech, Inc. STELARA (Biological) Food and Beverage In-kind items and services $117.18 General
Category: Immunology
02/28/2023 Mallinckrodt Hospital Products Inc. TERLIVAZ (Drug) Food and Beverage In-kind items and services $114.62 General
Category: CRITICAL CARE
11/05/2022 Mallinckrodt Hospital Products Inc. TERLIVAZ (Drug) Food and Beverage In-kind items and services $48.33 General
Category: CRITICAL CARE
08/18/2022 Regeneron Healthcare Solutions, Inc. DUPIXENT (Biological) Food and Beverage In-kind items and services $81.48 General
Category: INFLAMMATION AND IMMUNOLOGY
06/23/2021 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Food and Beverage In-kind items and services $18.97 General
Category: INTERNAL MEDICINE
06/16/2021 AbbVie Inc. HUMIRA (Biological) Food and Beverage In-kind items and services $17.13 General
Category: IMMUNOLOGY
06/07/2021 AbbVie Inc. HUMIRA (Biological) Food and Beverage In-kind items and services $29.59 General
Category: IMMUNOLOGY
05/26/2021 Gilead Sciences, Inc. Food and Beverage In-kind items and services $15.89 General
01/28/2021 PFIZER INC. ELIQUIS (Drug), VYNDAQEL Food and Beverage In-kind items and services $17.35 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
10/14/2020 Intercept Pharmaceuticals, Inc. OCALIVA (Drug) Food and Beverage In-kind items and services $15.36 General
Category: HEPATOLOGY GASTROENTEROLOGY
11/13/2019 Boston Scientific Corporation GENERAL - POLYPECTOMY (Device) Food and Beverage In-kind items and services $75.14 General
Category: POLYPECTOMY
01/23/2019 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Food and Beverage In-kind items and services $14.65 General
Category: INTERNAL MEDICINE

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 4 61 64 $53,790 $8,479
2022 4 81 81 $95,025 $11,254
2021 11 482 494 $294,984 $54,073
2020 7 172 175 $86,971 $20,274
Total Patients
796
Total Services
814
Medicare Billing
$94,080
Procedure Codes
26

All Medicare Procedures & Services

26 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2023 20 20 $29,000 $4,455 15.4%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 14 17 $3,740 $1,637 43.8%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2023 16 16 $18,080 $1,247 6.9%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 11 11 $2,970 $1,141 38.4%
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2022 32 32 $46,400 $6,845 14.8%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2022 25 25 $28,250 $1,795 6.4%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 11 11 $3,410 $1,574 46.2%
45380 Biopsy of large bowel using a flexible endoscope Facility 2022 13 13 $16,965 $1,041 6.1%
45385 Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare Facility 2021 52 52 $58,643 $11,109 18.9%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 58 58 $38,065 $7,669 20.1%
43239 Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope Facility 2021 88 89 $44,375 $7,106 16.0%
99222 Initial hospital inpatient care, typically 50 minutes per day Facility 2021 53 54 $27,069 $5,975 22.1%
45380 Biopsy of the large bowel using an endoscope (colonoscopy) Facility 2021 50 50 $38,451 $5,501 14.3%
99221 Initial hospital inpatient care, typically 30 minutes per day Facility 2021 51 52 $20,880 $4,314 20.7%
99203 New patient outpatient visit, total time 30-44 minutes Office 2021 38 38 $17,348 $3,289 19.0%
45378 Diagnostic examination of the colon (large bowel) using an endoscope(colonoscopy); high risk Facility 2021 21 21 $17,505 $3,214 18.4%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 41 49 $16,928 $3,019 17.8%
43235 Diagnostic examination of esophagus, stomach, and/or upper small bowel using an endoscope Facility 2021 17 17 $8,777 $1,604 18.3%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 13 14 $6,943 $1,273 18.3%
45385 Removal of polyps or growths of large bowel using an endoscope Facility 2020 22 22 $21,978 $4,962 22.6%
99222 Initial hospital inpatient care, typically 50 minutes per day Facility 2020 28 28 $12,236 $3,335 27.3%
99203 New patient office or other outpatient visit, typically 30 minutes Office 2020 35 35 $12,215 $3,035 24.8%
99204 New patient office or other outpatient visit, typically 45 minutes Office 2020 19 19 $10,051 $2,655 26.4%
43239 Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope Facility 2020 27 28 $11,660 $2,520 21.6%
45380 Biopsy of large bowel using an endoscope Facility 2020 20 20 $13,472 $2,248 16.7%

About Dr. Rishabh Sachdev, M.D

Dr. Rishabh Sachdev, M.D is a Gastroenterology healthcare provider based in Farmington, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/29/2014. The National Provider Identifier (NPI) number assigned to this provider is 1346650470.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rishabh Sachdev, M.D has received a total of $565.69 in payments from pharmaceutical and medical device companies, with $231.80 received in 2023. These payments were reported across 12 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($565.69).

As a Medicare-enrolled provider, Sachdev has provided services to 796 Medicare beneficiaries, totaling 814 services with total Medicare billing of $94,080. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.

Practice Information

  • Specialty Gastroenterology
  • Other Specialties Gastroenterology
  • Location Farmington, CT
  • Active Since 04/29/2014
  • Last Updated 09/26/2022
  • Taxonomy Code 207RG0100X
  • Entity Type Individual
  • NPI Number 1346650470

Products in Payments

  • TERLIVAZ (Drug) $162.95
  • STELARA (Biological) $117.18
  • DUPIXENT (Biological) $81.48
  • GENERAL - POLYPECTOMY (Device) $75.14
  • HUMIRA (Biological) $46.72
  • ENTYVIO (Biological) $33.62
  • ELIQUIS (Drug) $17.35
  • OCALIVA (Drug) $15.36

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Gastroenterology Doctors in Farmington